https://cogentia.co.uk/news/cogentia-at-ispor-europe-2026/ 2026-11-05T13:07:39+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-ISPOR-2026.webp https://cogentia.co.uk/wp-content/uploads/2026/10/5-1024x1024.png https://cogentia.co.uk/wp-content/uploads/2026/10/2-1024x1024.png https://cogentia.co.uk/wp-content/uploads/2026/10/3-1024x1024.png https://cogentia.co.uk/wp-content/uploads/2026/10/4-1024x1024.png https://cogentia.co.uk/publications/deal-or-no-deal-the-evolving-use-of-commercial-arrangements-in-nice-appraisals/ 2026-11-05T13:09:20+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Deal-or-No-Deal.webp https://cogentia.co.uk/news/cogentia-welcomes-new-team-members/ 2026-11-05T13:10:36+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-New-Starters.webp https://cogentia.co.uk/wp-content/uploads/2026/10/news_mia.webp https://cogentia.co.uk/wp-content/uploads/2026/10/news_samuel.webp https://cogentia.co.uk/news/cogentia-at-the-cambridge-dragon-boat-festival-2026/ 2026-11-05T13:11:11+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Dragon-Boat.webp https://cogentia.co.uk/publications/from-pipeline-to-pricing-and-reimbursement-trends-in-the-gene-therapy-landscape-and-implications-for-the-future/ 2026-11-05T13:11:42+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Pricing-to-Pipeline.webp https://cogentia.co.uk/publications/better-off-dead-mitigating-for-situations-where-improving-survival-isnt-cost-effective/ 2026-11-05T13:12:11+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Better-off-dead.webp https://cogentia.co.uk/publications/advancements-in-digital-health-current-landscape-evaluation-processes-for-us-uk-eu4-markets/ 2026-11-05T13:12:45+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Advancements-in-Digital-Health.webp https://cogentia.co.uk/publications/interlinked-cost-effectiveness-analysis-and-forecast-modelling-as-a-tool-to-guide-strategic-clinical-and-commercial-development/ 2026-11-05T13:13:16+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-Cost-Effectiveness.webp https://cogentia.co.uk/publications/nices-proportionate-approach-is-it-working-time-to-access-for-cost-comparison-vs-single-technology-appraisals/ 2026-11-05T13:21:18+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-NICE-proportional-approach.webp https://cogentia.co.uk/publications/imf-the-innovative-medicines-fund-or-the-interim-medicines-fund/ 2026-11-05T13:21:39+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-IMF.webp https://cogentia.co.uk/publications/stem-cell-therapeutics-the-need-for-early-market-access/ 2026-11-05T13:21:59+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-STEM-Cell-Therapeutics.webp https://cogentia.co.uk/publications/how-is-the-updated-nice-hst-criteria-impacting-the-number-of-drugs-routed-and-how-can-companies-prepare/ 2026-11-06T14:59:37+00:00 https://cogentia.co.uk/wp-content/uploads/2026/10/Web-News-Tile-NICE-HST-criteria.webp